Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 56.45-75.8944.4928.15260.73

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is 56.45 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar202356.45
Mar2022-75.89
Mar202144.49
Mar202028.15
Mar2019260.73

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49
58.05
Mar2020 28.15
-89.20
Mar2019 260.73 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹1,851.7 Cr -3.7% 24.9% 43.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹363,535.0 Cr 0.9% -6.6% 58.8% Stock Analytics
CIPLA ₹112,058.0 Cr -1% -5.6% 54.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-3.7%

24.9%

43.5%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses